Cyclooxygenase-2 enhances antimicrobial peptide expression and killing of staphylococcus aureus

Journal of Immunology

Volumn 185, Issue 11, 2010, Pages 6535-6544

  Bernard, Jamie J ^a   Gallo, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR;

ARTICLE; BACTERICIDAL ACTIVITY; BIOLOGICAL ACTIVITY; CELL STIMULATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET B RADIATION;

ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; KERATINOCYTES; LIGANDS; STAPHYLOCOCCUS AUREUS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 6; UP-REGULATION;

EID: 78650658462     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002009     Document Type: Article

References (50)

1. Lebre, M. C., A. M. van der Aar, L. van Baarsen, T. M. van Capel J. H. Schuitemaker, M. L. Kapsenberg, and E. C. de Jong. 2007. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127:331-341.
2. Kawai, K., H. Shimura, M. Minagawa, A. Ito, K. Tomiyama, and M. Ito. 2002. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J. Dermatol. Sci. 30:185-194.
3. Pivarcsi, A., L. Kemény, and A. Dobozy. 2004. Innate immune functions of the keratinocytes: a review. Acta Microbiol. Immunol. Hung. 51:303-310.
4. Sugita, K., K. Kabashima, K. Atarashi, T. Shimauchi, M. Kobayashi, and Y. Tokura. 2007. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin. Exp. Immunol. 147:176-183.
5. Lai, Y., and R. L. Gallo. 2009. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 30:131-141.
6. Yamasaki, K., and R. L. Gallo. 2008. Antimicrobial peptides in human skin disease. Eur. J. Dermatol. 18:11-21.
7. Braff, M. H., and R. L. Gallo. 2006. Antimicrobial peptides: an essential component of the skin defensive barrier. Curr. Top. Microbiol. Immunol. 306:91-110.
8. Scott, M. G., and R. E. Hancock. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit. Rev. Immunol. 20:407-431.
9. Tani, K., W. J. Murphy, O. Chertov, R. Salcedo, C. Y. Koh, I. Utsunomiya, S. Funakoshi, O. Asai, S. H. Herrmann, J. M. Wang, et al. 2000. Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens. Int. Immunol. 12:691-700.
10. Gallo, R. L., and K. M. Huttner. 1998. Antimicrobial peptides: an emerging concept in cutaneous biology. J. Invest. Dermatol. 111:739-743.
11. Schauber, J., and R. L. Gallo. 2009. Antimicrobial peptides and the skin immune defense system. J. Allergy Clin. Immunol. 124 (Suppl. 2): R13-R18.
12. Ong, P. Y., T. Ohtake, C. Brandt, I. Strickland, M. Boguniewicz, T. Ganz, R. L. Gallo, and D. Y. Leung. 2002. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347:1151-1160.
13. Yamasaki, K., A. di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R. A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, et al. 2007. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat. Med. 13:975-980.
14. Wehkamp, J., K. Fellermann, K. R. Herrlinger, S. Baxmann, K. Schmidt, B. Schwind, M. Duchrow, C. Wohlschläger, A. C. Feller, and E. F. Stange. 2002. Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 14:745-752.
15. Rajakariar, R., M. M. Yaqoob, and D. W. Gilroy. 2006. COX-2 in inflammation and resolution. Mol. Interv. 6:199-207.
16. Chen, Y., J. Zhang, S. A. Moore, Z. K. Ballas, J. P. Portanova, A. M. Krieg, and D. J. Berg. 2001. CpG DNA induces cyclooxygenase-2 expression and prostaglandin production. Int. Immunol. 13:1013-1020. (Pubitemid 32750504)
17. Iñiguez, M. A., C. Punzón, and M. Fresno. 1999. Induction of cyclooxygenase-2 on activated T lymphocytes: regulation of T cell activation by cyclooxygenase-2 inhibitors. J. Immunol. 163:111-119.
18. Aronoff, D. M., C. Canetti, and M. Peters-Golden. 2004. Prostaglandin E2 inhibits alveolar macrophage phagocytosis through an E-prostanoid 2 receptormediated increase in intracellular cyclic AMP. J. Immunol. 173:559-565.
19. Aronoff, D. M., Y. Hao, J. Chung, N. Coleman, C. Lewis, C. M. Peres, C. H. Serezani, G. H. Chen, N. Flamand, T. G. Brock, and M. Peters-Golden. 2008. Misoprostol impairs female reproductive tract innate immunity against Clostridium sordellii. J. Immunol. 180:8222-8230.
20. Bernard, M. P., S. Bancos, T. J. Chapman, E. P. Ryan, J. J. Treanor, R. C. Rose, D. J. Topham, and R. P. Phipps. 2010. Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection. Vaccine 28:1363-1372.
21. Mulla, Z. D., and S. G. Gibbs. 2005. Invasive group A streptococcal disease: race, hypotension, and immunogenetics. Ethn. Dis. 15 (Suppl. 5): S5-63-S5-66.
22. Stevens, D. L. 1995. Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? Clin. Infect. Dis. 21:977-980.
23. Factor, S. H., O. S. Levine, L. H. Harrison, M. M. Farley, A. McGeer, T. Skoff, C. Wright, B. Schwartz, and A. Schuchat. 2005. Risk factors for pediatric invasive group A streptococcal disease. Emerg. Infect. Dis. 11:1062-1066.
24. Gonzalez, B. E., G. Martinez-Aguilar, K. G. Hulten, W. A. Hammerman, J. Coss-Bu, A. Avalos-Mishaan, E. O. Mason, Jr., and S. L. Kaplan. 2005. Severe Staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics 115:642-648.
25. Wang, B., N. Ruiz, A. Pentland, and M. Caparon. 1997. Keratinocyte proinflammatory responses to adherent and nonadherent group A streptococci. Infect. Immun. 65:2119-2126.
26. Barton, L. L. 2005. Nonsteroidal anti-inflammatory drugs and invasive staphylococcal infections: the cart or the horse? Pediatrics 115:1790.
27. Pivarcsi, A., I. Nagy, A. Koreck, K. Kis, A. Kenderessy-Szabo, M. Szell, A. Dobozy, and L. Kemeny. 2005. Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human β-defensin-2 in vaginal epithelial cells. Microbes Infect. 7:1117-1127.
28. Ryan, E. P., S. J. Pollock, S. J. Pollock, T. I. Murant, S. H. Bernstein, R. E. Felgar, and R. P. Phipps. 2005. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J. Immunol. 174:2619-2626.
29. Schaefer, T. M., J. V. Fahey, J. A. Wright, and C. R. Wira. 2005. Innate immunity in the human female reproductive tract: antiviral response of uterine epithelial cells to the TLR3 agonist poly (I:C). J. Immunol. 174:992-1002.
30. Gläser, R., F. Navid, W. Schuller, C. Jantschitsch, J. Harder, J. M. Schröder, A. Schwarz, and T. Schwarz. 2009. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J. Allergy Clin. Immunol. 123:1117-1123.
31. Hong, S. P., M. J. Kim, M. Y. Jung, H. Jeon, J. Goo, S. K. Ahn, S. H. Lee, P. M. Elias, and E. H. Choi. 2008. Biopositive effects of low-dose UVB on epidermis: coordinate upregulation of antimicrobial peptides and permeability barrier reinforcement. J. Invest. Dermatol. 128:2880-2887.
32. Buckman, S. Y., A. Gresham, P. Hale, G. Hruza, J. Anast, J. Masferrer, and A. P. Pentland. 1998. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 19:723-729.
33. 2 receptors, EP2 and EP4. Cancer Res. 67:2015-2021.
34. Liu, L., L. Wang, H. P. Jia, C. Zhao, H. H. Heng, B. C. Schutte, P. B. McCray, Jr., and T. Ganz. 1998. Structure and mapping of the human β-defensin HBD-2 gene and its expression at sites of inflammation. Gene 222:237-244.
35. Wehkamp, K., L. Schwichtenberg, J. M. Schröder, and J. Harder. 2006. Pseudomonas aeruginosa-and IL-1β-mediated induction of human β-defensin-2 in keratinocytes is controlled by NF-κB and AP-1. J. Invest. Dermatol. 126:121-127.
36. Peschel, A., and L. V. Collins. 2001. Staphylococcal resistance to antimicrobial peptides of mammalian and bacterial origin. Peptides 22:1651-1659.
37. Menzies, B. E., and A. Kenoyer. 2006. Signal transduction and nuclear responses in Staphylococcus aureus-induced expression of human β-defensin 3 in skin keratinocytes. Infect. Immun. 74:6847-6854.
38. Gallo, R. L. 2008. Sounding the alarm: multiple functions of host defense peptides. J. Invest. Dermatol. 128:5-6.
39. 2 induces the production of human β-defensin-3 in human keratinocytes. Biochem. Pharmacol. 79:982-989.
40. Kim, Y. I., J. W. Lee, M. H. Lee, S. W. Park, B. N. Cho, and H. K. Lee. 2010. Effects of 15-deoxy-Δ12, 14-prostaglandin J2 on the production of IL-8 and the expression of Toll-like receptor 2 in human primary keratinocytes stimulated with lipopolysaccharide. Mol. Biol. Rep. DOI: 10.1007/s11033-010- 9993-5.
41. 2: the endogenous electrophile that induces neuronal apoptosis. Proc. Natl. Acad. Sci. USA 99:7367-7372.
42. Shibata, T., T. Yamada, T. Ishii, S. Kumazawa, H. Nakamura, H. Masutani, J. Yodoi, and K. Uchida. 2003. Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem. 278:26046-26054.
43. Kanda, N., and S. Watanabe. 2008. Leptin enhances human β-defensin-2 production in human keratinocytes. Endocrinology 149:5189-5198.
44. Scharf, S., S. Hippenstiel, A. Flieger, N. Suttorp, and P. D. N'Guessan. 2010. Induction of human β-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: involvement of TLR2 and TLR5, p38 MAPK, JNK, NF-κB and AP-1. Am. J. Physiol. Lung Cell. Mol. Physiol. 298: L687-L695.
45. Jang, B. C., K. J. Lim, J. H. Paik, Y. K. Kwon, S. W. Shin, S. C. Kim, T. Y. Jung, T. K. Kwon, J. W. Cho, W. K. Baek, et al. 2004. Up-regulation of human β-defensin 2 by interleukin-1β in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kB. Biochem. Biophys. Res. Commun. 320:1026-1033.
46. Krisanaprakornkit, S., J. R. Kimball, and B. A. Dale. 2002. Regulation of human β-defensin-2 in gingival epithelial cells: the involvement of mitogen-activated protein kinase pathways, but not the NF-κB transcription factor family. J. Immunol. 168:316-324.
47. Kisich, K. O., M. D. Howell, M. Boguniewicz, H. R. Heizer, N. U. Watson, and D. Y. Leung. 2007. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on b-defensin 3. J. Invest. Dermatol. 127:2368-2380.
48. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-395.
49. Reygaert, W. 2009. Methicillin-resistant Staphylococcus aureus (MRSA): molecular aspects of antimicrobial resistance and virulence. Clin. Lab. Sci. 22:115-119.
50. Cantón, R. 2009. Antibiotic resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting. Clin. Microbiol. Infect. 15 (Suppl. 1):20-25.